HINDER PROTECTING USA FROM EBOLA
Cutter said, “Money towards the Ebola vaccine is basically cut in half to what it was,” and “more cuts are coming under the congressional sequester.”
Whether money for the vaccine was cut in half depends on the metric you use. It’s true if you compare 2010 to the 2014 estimate, when vaccine research spending fell $37 million to $17.2 million, but not if you use other parameters.
The financial picture for the NIH is not expected to substantially brighten any time soon amid constraints from budget-control measures, though given the emergence of the threat in the United States and the massive attention to the issue, Congress and the president could choose to increase funding for Ebola going forward.
We rate her claim Mostly True.